Detalhe da pesquisa
1.
Pervasive chromosomal instability and karyotype order in tumour evolution.
Nature
; 587(7832): 126-132, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32879494
2.
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme.
Histopathology
; 83(1): 91-103, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999648
3.
Seeing the forest and the tree: TILs and PD-L1 as immune biomarkers.
Breast Cancer Res Treat
; 189(3): 599-606, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487294
4.
Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Breast Cancer Res
; 22(1): 91, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32811538
5.
Molecular comparison of interval and screen-detected breast cancers.
J Pathol
; 248(2): 243-252, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30746706
6.
Checkpoint blockade in the treatment of breast cancer: current status and future directions.
Br J Cancer
; 119(1): 4-11, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29808015
7.
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study.
Lancet Oncol
; 18(1): 52-62, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27964843
8.
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
Lancet Oncol
; 18(8): 1009-1021, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28694034
9.
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Breast Cancer Res
; 24(1): 50, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841108
10.
Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
PLoS Med
; 14(4): e1002302, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28430777
11.
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.
Mod Pathol
; 30(7): 952-963, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28338653
12.
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
PLoS Med
; 13(12): e1002204, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28027312
13.
Relevance of tumor-infiltrating lymphocytes in breast cancer.
BMC Med
; 13: 202, 2015 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26300242
14.
Oncogene addiction and immunity: clinical implications of tumour infiltrating lymphocytes in breast cancers overexpressing the HER2/neu oncogene.
Curr Opin Oncol
; 26(6): 562-7, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25188474
15.
The anti-cancer immune response in breast cancer: current and emerging biomarkers and treatments.
Trends Cancer
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521654
16.
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.
Clin Cancer Res
; 30(4): 767-778, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060199
17.
Tucatinib promotes immune activation and synergizes with programmed cell death-1 and programmed cell death-ligand 1 inhibition in HER2-positive breast cancer.
J Natl Cancer Inst
; 115(7): 805-814, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166471
18.
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 68, 2023 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37582853
19.
Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.
Cancer Cell
; 41(3): 585-601.e8, 2023 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827978
20.
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Cell Rep
; 42(8): 113014, 2023 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605534